You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:恒指升0.84%,恒科指升2.26%,美團、招商銀行升超5%

2月14日,美國通脹高於預期,但港股農曆新年假期期間休市兩天期間環球股市上升,港股龍年首個交易日低開高走。截至全天收盤,恒指升0.84%報15879.38點,恒生科技指數升2.26%報3197.87點,國企指數升1.5%報5386.31點。

科技股升幅居前,小鵬汽車升近8%,閲文集團、東方甄選升超6%,美團、招商銀行升超5%,攜程、萬國數據升超4%,京東集團升3.5%,金山軟件、快手、理想汽車、舜宇、中芯國際、阿里巴巴升超2%。

具體來看

內地銀行午後震盪上揚,招商銀行升超5%,中銀香港、工商銀行、農業銀行、中國銀行和建設銀行跟升。

消息面,1月金融數據超預期,機構看好銀行板塊底部配置機遇。

教育概念港股午後升幅擴大,思考樂教育升超20%,卓越教育集團、東方甄選、新東方-S等紛紛跟升。

消息方面,教育部2月9日面向社會《校外培訓管理條例(徵求意見稿)》公開徵求意見。面向義務教育階段學生實施的學科類校外培訓,應當依法實行政府指導價管理,由省級人民政府制定收費管理辦法。

部分節假日概念港股午後繼續走強,美蘭空港升近12%,美團-W升超5%,同程旅行升超3%。

消息方面,春運啟動以來,中國聯通2月13日的智慧足跡大數據顯示,全國重點文旅景點的遊客數量達到了1.23億人次,較去年同期增長了22.8%。單個省市方面,海南省旅遊主管部門就出島機票緊張的問題表示,春運海南客流整體同比增長30%以上。

博彩股升幅居前,美高梅升近10%,銀河娛樂、永利澳門升超3%,金沙中國跟升。

CRO板塊集體下挫,藥明康德跌超18%,藥明生物跌超9%,泰格醫藥跌近4%、康龍化成跌超2%。

消息方面,由美國參議院議員加里·彼得斯(Gary Peters)在2023年12月20日提出的S.3558提案(即參院版《生物安全法》)的共同發起議員(Cosponsor)人數已由6位增至7位。

內房股普跌,遠洋集團跌超4%,雅居樂跌超3%,龍湖集團、中國金茂等跟跌。

消息面上,2月9日,華南城發佈公吿稱,近年來,因外部因素變化,公司銷售不及預期,現金流只能保證日常經營所需。上述因素的疊加效應導致流動資金日趨緊張。因此,在債務上面臨着非常大的還本付息壓力。

展望後市,中金策略研報稱,在較低的估值水平和悲觀的情緒下,只要一些積極催化劑出現就可以帶來修復式的快速反彈。但這一反彈與持續的趨勢逆轉還有很大差距。在政策託底有望給市場提供一定支撐,投資者可以採取“撿便宜”策略。不過,在更多利好性政策兑現前,當前環境下整體啞鈴型配置策略仍行之有效。

穩定現金流板塊(高分紅比例,如電信、公用事業和能源)、高端科技升級板塊(科技硬件、半導體)和中端優勢行業出海板塊(工程機械、汽車與零部件、新能源與光伏、部分品牌消費等)將是核心關注的三條主線。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account